ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

High Dose Radiotherapy Plus Chemo Encouraging For Small Cell Lung Cancer

November 27, 2009

DRCCA Board Gives Concept Approval To Nutrition Clinical Trials Which Could Total $52.5 Million

January 28, 1983

House Committee on Appropriations approves $28.5 billion for NIH.

June 24, 2005

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

December 27, 2013

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995